
Sign up to save your podcasts
Or


This podcast, which overviews Digital Health Technologies and Behavior Change, has been created by the Montefiore Einstein Innovation Biodesign Training Program.
Link - https://www.einstein.yu.edu/departments/medicine/innovation/biodesign-training/
The podcast's host is Dr. Nijas Nazar, an Emergency Department Hospitalist at Montefiore.
This podcast's guest is Dr. Jonathan Feldman, an Associate Professor of Pediatrics at Montefiore Einstein and Professor of Psychology at the Ferkauf Graduate School of Psychology of Yeshiva University. Dr. Feldman is the Director of the Health Psychology Service at the Max & Celia Parnes Family Psychological and Psychoeducational Services Clinic. He is an expert in health behavior change in asthma, asthma symptom perception, medication adherence, psychiatric disorders, and clinical health psychology. Dr. Feldman has extensive experience conducting randomized controlled trials of behavioral interventions in ethnic minority, inner-city children and adults with asthma and has received multiple R01 grant awards through the NIH.
By Montefiore Innovation Biodesign5
22 ratings
This podcast, which overviews Digital Health Technologies and Behavior Change, has been created by the Montefiore Einstein Innovation Biodesign Training Program.
Link - https://www.einstein.yu.edu/departments/medicine/innovation/biodesign-training/
The podcast's host is Dr. Nijas Nazar, an Emergency Department Hospitalist at Montefiore.
This podcast's guest is Dr. Jonathan Feldman, an Associate Professor of Pediatrics at Montefiore Einstein and Professor of Psychology at the Ferkauf Graduate School of Psychology of Yeshiva University. Dr. Feldman is the Director of the Health Psychology Service at the Max & Celia Parnes Family Psychological and Psychoeducational Services Clinic. He is an expert in health behavior change in asthma, asthma symptom perception, medication adherence, psychiatric disorders, and clinical health psychology. Dr. Feldman has extensive experience conducting randomized controlled trials of behavioral interventions in ethnic minority, inner-city children and adults with asthma and has received multiple R01 grant awards through the NIH.